Home/Filings/4/0001062993-22-008403
4//SEC Filing

Opfermann Andreas 4

Accession 0001062993-22-008403

CIK 0001707925other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 2:23 PM ET

Size

34.9 KB

Accession

0001062993-22-008403

Insider Transaction Report

Form 4
Period: 2022-03-21
Opfermann Andreas
Executive VP, Americas
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-03-21+9601,506 total
  • Award

    Performance Share Units

    2022-03-21+960960 total
    Ordinary Shares (960 underlying)
  • Exercise/Conversion

    Performance Share Units

    2022-03-214800 total
    Ordinary Shares (480 underlying)
  • Tax Payment

    Ordinary Shares

    2022-03-21$311.66/sh456$142,1171,050 total
  • Exercise/Conversion

    Ordinary Shares

    2022-03-21+4801,530 total
  • Tax Payment

    Ordinary Shares

    2022-03-21$311.66/sh228$71,0581,302 total
  • Exercise/Conversion

    Ordinary Shares

    2022-03-21+3201,622 total
  • Tax Payment

    Ordinary Shares

    2022-03-21$311.66/sh152$47,3721,470 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-213200 total
    Ordinary Shares (320 underlying)
  • Exercise/Conversion

    Performance Share Units

    2022-03-219600 total
    Ordinary Shares (960 underlying)
  • Award

    Performance Share Units

    2022-03-21+480480 total
    Ordinary Shares (480 underlying)
Holdings
  • Restricted Stock Units

    Exercise: $0.00Ordinary Shares (2,145 underlying)
    2,145
  • Stock Option (right to buy)

    Exercise: $173.13From: 2021-03-09Exp: 2030-03-09Ordinary Shares (26,090 underlying)
    26,090
  • Stock Option (right to buy)

    Exercise: $1.92From: 2021-06-07Exp: 2022-06-07Ordinary Shares (387 underlying)
    387
  • Restricted Stock Units

    Exercise: $0.00Ordinary Shares (1,365 underlying)
    1,365
  • Restricted Stock Units

    Exercise: $0.00Ordinary Shares (1,810 underlying)
    1,810
  • Stock Options (right to buy)

    Exercise: $270.99From: 2023-03-07Exp: 2032-03-07Ordinary Shares (11,830 underlying)
    11,830
  • Stock Option (right to buy)

    Exercise: $253.68From: 2022-03-08Exp: 2031-03-08Ordinary Shares (19,070 underlying)
    19,070
  • Stock Option (right to buy)

    Exercise: $176.63From: 2020-03-20Exp: 2029-03-20Ordinary Shares (3,600 underlying)
    3,600
Footnotes (13)
  • [F1]Shares of common stock acquired pursuant to the payout of a performance share unit grant made on March 20, 2019 (the "PSU").
  • [F10]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
  • [F11]This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
  • [F12]Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
  • [F13]This option vests over three years in three consecutive equal annual installments beginning on March 20,2020.
  • [F2]Shares of common stock withheld from the payout to cover tax withholdings.
  • [F3]Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019.
  • [F4]The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.
  • [F5]The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.
  • [F6]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F7]Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F8]Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
  • [F9]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

Issuer

LINDE PLC

CIK 0001707925

Entity typeother

Related Parties

1
  • filerCIK 0001793274

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 2:23 PM ET
Size
34.9 KB